Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
about
Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesisSIBLINGs and SPARC families: their emerging roles in pancreatic cancerOsteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.Pre- and post-translational regulation of osteopontin in cancer.Nuclear osteopontin-c is a prognostic breast cancer marker.Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinomaRole of IL-6 in the resolution of pancreatitis in obese miceRole of the metastasis-promoting protein osteopontin in the tumour microenvironment.The osteopontin-c splice junction is important for anchorage-independent growth.RNA blood levels of osteopontin splice variants are cancer markers.Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry.Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.Osteopontin expression in healing wounds of horses and in human keloids.
P2860
Q26996794-82DA996B-4253-4027-B9EF-73BADACC2FB6Q27027759-AFF05F73-89F8-4776-B5BF-30AC5F5EFBD6Q28509843-13D5AFF3-2DC0-4CC5-82B0-117D2291279CQ30318127-391C2605-CD97-4388-BD4B-F9429C97A1DFQ34939938-18701BA6-0241-4B47-B22D-D1D6199ED212Q35098350-C79E8F4A-51F8-47CD-A97B-52AF18DDFADEQ35735234-92980A32-E207-4134-AA31-A42D46B429E9Q35988584-06E88A3A-6F22-466D-9A11-552DE20F0B00Q37769582-84D64074-3B6E-4EF3-AA62-51953BD05312Q39202707-7AE125B5-04E7-41F1-AE33-F93B391E7696Q39324580-72F0534D-E7B5-4838-AC53-C7ABE1F907BFQ39424574-EC049CC7-F411-42A9-AF8A-5869004FCB88Q39588669-C01ABE5F-8225-4DEA-996C-FC49396E367FQ39688172-1D6CD367-C349-40C4-88AD-BBE7D17185D8Q41590198-8F24A97C-8C32-47DB-B170-88BB3F4E78AEQ47357582-E3FEE261-B142-4435-BDA7-28A908F11A74Q48263513-47216EBC-193D-404F-BF07-848AB1D59041
P2860
Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@en
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@nl
type
label
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@en
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@nl
prefLabel
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@en
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
Expression of a prometastatic ...... creatic ductal adenocarcinoma.
@en
P2093
Agnes Witkiewicz
Amer Alnajar
Charles J Yeo
Chee Yuan Ng
David T Denhardt
Galina Chipitsyna
Georg F Weber
Hwyda A Arafat
Jennifer Sullivan
Laurel Blair
P2860
P304
P356
10.1016/J.SURG.2009.03.036
P407
P577
2009-08-01T00:00:00Z